| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |